dw a 2114r has been researched along with Fibrosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akamatsu, K; Endo, K; Kaiho, S; Koizumi, K; Koizumi, M; Matsumoto, T; Mitsui, H; Morikawa, K; Tsunenari, T | 1 |
| Akamatsu, K; Endo, K; Kamisango, K; Koizumi, K; Koizumi, M; Matsumoto, T; Matsuno, T; Mitsui, H; Morikawa, K | 1 |
2 other study(ies) available for dw a 2114r and Fibrosarcoma
| Article | Year |
|---|---|
[Combination therapy of a new platinum complex, DWA2114R with various antitumor agents against mouse tumors in vivo].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fibrosarcoma; Fluorouracil; Leukemia P388; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Ovarian Neoplasms; Sarcoma, Experimental; Vindesine | 1992 |
[Antitumor activity of a new platinum complex (R)-(-)-2-aminomethylpyrrolidine (1,1-cyclobutane dicarboxylato) platinum (II) (DWA2114R) by its serial administration].
Topics: Animals; Antineoplastic Agents; Carboplatin; Drug Screening Assays, Antitumor; Drug Tolerance; Fibrosarcoma; Injections, Intraperitoneal; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Organoplatinum Compounds; Weight Loss | 1989 |